• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study

tetano

Editor, Senior Moderator
J Clin Virol. 2016 Apr 12;79:68-73. doi: 10.1016/j.jcv.2016.04.005. [Epub ahead of print]
[h=1]Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study.[/h] Loubet P[SUP]1[/SUP], Samih-Lenzi N[SUP]2[/SUP], Galtier F[SUP]3[/SUP], Vanhems P[SUP]4[/SUP], Loulergue P[SUP]5[/SUP], Duval X[SUP]6[/SUP], Jouneau S[SUP]7[/SUP], Postil D[SUP]8[/SUP], Rogez S[SUP]9[/SUP], Valette M[SUP]10[/SUP], Merle C[SUP]11[/SUP], R?gis C[SUP]12[/SUP], Costa Y[SUP]13[/SUP], Lesieur Z[SUP]2[/SUP], Tattevin P[SUP]14[/SUP], Lina B[SUP]10[/SUP], Carrat F[SUP]15[/SUP], Launay O[SUP]16[/SUP]; FLUVAC Study Group.
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Influenza is an important cause of serious illness and death, particularly in elderly and high-risk groups.
[h=4]OBJECTIVES:[/h] Aim of this study was to identify factors associated with poor outcomes among adults hospitalized in France for laboratory-confirmed seasonal influenza.
[h=4]STUDY DESIGN:[/h] Patients hospitalized for influenza were identified in a prospective, multicenter study carried out in French hospitals during three consecutive influenza seasons (2012-2015). Influenza virus infection was confirmed by reverse transcription polymerase chain reaction. Sociodemographic and clinical variables were compared according to the virus type and subtype. Risk factors for complications, intensive care unit (ICU) admission and death were analyzed by backward stepwise logistic regression.
[h=4]RESULTS:[/h] The study population consisted of 566 patients, of whom 56% were older than 65 years and 82% had underlying chronic illnesses. Type A influenza viruses infected 422 patients (75%), including subtype H3N2 in 239 patients (57%). The prior vaccine coverage rate was 38%. Complications occurred in 255 patients (45%), consisting mainly of pneumonia (n=143, 30%) and respiratory failure (n=116, 20%). Eighty-three patients (15%) were admitted to an ICU, and the in-hospital mortality rate was 4% (n=21). Sixty-six patients (12%) received oseltamivir. Age over 65 years was the only identified risk factor for complications. Risk factors for ICU admission were an absence of vaccination, no oseltamivir administration before admission, pre-existing chronic respiratory disease, and current smoking. Age over 65 years and ICU admission were risk factors for death.
[h=4]CONCLUSIONS:[/h] Older individuals and patients with underlying conditions are most at risk of influenza complications. Vaccination and early oseltamivir administration, both of which are recommended for these patients, appear to reduce ICU admissions.
Copyright ? 2016 Elsevier B.V. All rights reserved.


[h=4]KEYWORDS:[/h] Adults; Antiviral; Hospitalisation; Influenza; Severe; Vaccination

PMID: 27105315 [PubMed - as supplied by publisher]
 
Back
Top Bottom